Implications of atrial fibrillation on the clinical course and outcomes of hospitalized COVID-19 patients: results of the Cardio-COVID-Italy multicentre study
暂无分享,去创建一个
C. Specchia | M. Metra | M. Senni | I. Porto | M. Guazzi | M. Piepoli | M. L. La Rovere | A. Mortara | M. Gnecchi | S. Carugo | S. Leonardi | M. Volterrani | A. Iorio | G. Sinagra | M. Mapelli | P. Agostoni | A. Bellasi | M. Merlo | F. Sarullo | P. Ameri | G. Maccagni | A. Pozzi | C. Lombardi | S. París | R. Camporotondo | L. D. Dalla Vecchia | R. Inciardi | D. Tomasoni | V. Carubelli | V. Nuzzi | L. Monzo | S. Giovinazzo | C. Canale | G. Danzi | G. Zaccone | Mattia Di Pasquale | Francesco Catagnano | Davide Margonato | Giovanni Provenzale | Chiara Tedino | G. Provenzale
[1] G. Boriani,et al. Clinical and electrocardiographic characteristics at admission of COVID-19/SARS-CoV2 pneumonia infection , 2021, Internal and Emergency Medicine.
[2] J. Ludvigsson,et al. Direct oral anticoagulant use and risk of severe COVID‐19 , 2020, Journal of internal medicine.
[3] M. Metra,et al. Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID‐19. Results of the Cardio‐COVID‐Italy multicentre study , 2020, European journal of heart failure.
[4] S. Markowitz,et al. Outcomes and mortality associated with atrial arrhythmias among patients hospitalized with COVID‐19 , 2020, Journal of cardiovascular electrophysiology.
[5] M. Bertini,et al. Electrocardiographic features of 431 consecutive, critically ill COVID-19 patients: an insight into the mechanisms of cardiac involvement , 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[6] S. Markowitz,et al. Arrhythmic Complications of Patients Hospitalized With COVID-19 , 2020, Circulation. Arrhythmia and electrophysiology.
[7] Jeroen J. Bax,et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). , 2020, European heart journal.
[8] Marco Merlo,et al. Association of Troponin Levels With Mortality in Italian Patients Hospitalized With Coronavirus Disease 2019: Results of a Multicenter Study. , 2020, JAMA cardiology.
[9] S. Solomon,et al. Coronavirus 2019 Disease (COVID‐19), Systemic Inflammation, and Cardiovascular Disease , 2020, Journal of the American Heart Association.
[10] M. Metra,et al. Atrial fibrillation in the COVID-19 era: simple bystander or marker of increased risk? , 2020, European heart journal.
[11] W. Shen,et al. Guidance on Short‐Term Management of Atrial Fibrillation in Coronavirus Disease 2019 , 2020, Journal of the American Heart Association.
[12] Dhanunjaya R. Lakkireddy,et al. COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies , 2020, Journal of Interventional Cardiac Electrophysiology.
[13] G. Kay,et al. Atrial Arrhythmias in COVID-19 Patients , 2020, JACC: Clinical Electrophysiology.
[14] S. Solomon,et al. COVID‐19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease , 2020, European journal of heart failure.
[15] C. Specchia,et al. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy , 2020, European heart journal.
[16] Tao Guo,et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) , 2020, JAMA cardiology.
[17] K. Yuen,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.
[18] S. Solomon,et al. Left atrial structure and function and the risk of death or heart failure in atrial fibrillation , 2019, European journal of heart failure.
[19] G. Bernard,et al. Atrial Fibrillation Is an Independent Predictor of Mortality in Critically Ill Patients* , 2015, Critical care medicine.
[20] Sudha Seshadri,et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study , 2015, The Lancet.